Real-world evidence data (RWED) of Financial Toxicity in Patients Receiving Cancer Immunotherapy Treatments
Researched by Belong.Life and published by ASCO 2020 Authors: D A Vorobiof, L Hasid, I Deutsch, A Litvin, E Malki Abstract: RWED of financial toxicity was reported by the majority of cancer pts receiving Immunotherapy drugs for treatment of their solid tumors. 48% of the pts were aware of possible FTs as a result of […]
Using a digital patient powered research network to identify outcomes of importance to patients with multiple myeloma
Authors: Katharine S. Gries & John Fastenau Background: Social media platforms give patients a voice by allowing them to discuss their health and connect with others. These unfiltered and genuine reports offer direct access to what matters most to patients. Exploring the patient-reported outcomes discussed in these platforms reveal clinical insights and behavioral patterns of […]
Covid 19 vaccines in cancer patients (pts), real-world data (RWD) from 1069 Belong.life users
Authors: Eli Sapir, Noy Moisa, Alon Litvin, Eliran Malki, Daniel Vorobiof, Assuta Ashdod Hospital Background: The COVID-19 pandemic continues to have a serious impact on cancer pts management. At the end of December 2020, the US CDC and oncology groups (ASCO, ESMO, ACS) made general vaccine recommendations for cancer pts. Methods: HODS 1069 patients, users […]
Evaluating the dyadic management of sexuality-related parameters in women with early breast cancer (EBC): The emergence of “partner reported outcome measurements” (pROMs).
Researched by Belong.Life and published by ASCO Authors: Eli Sapir, Benjamin W. Corn, Lior Hasid, Irad Deutsch, Daniel A. Vorobiof Background:Patient-centered healthcare has focused on incorporating the values of patients (Pts) during clinical decision-making. Accordingly, assessments are often executed with patient reported outcome measurements (PROMs). In the context of tumors located in a sexual organ, […]
Clinical trials participation is directly influenced by the information received by cancer patients (pts) and caregivers: Real-world evidence with the use of a specialized digital health platform.
Researched by Belong.Life and published by ASCO Authors: Keren Greenfeld-Barsky, Lior Hasid, Daniel A. Vorobiof, Eliran Malki Background: Clinical trials (CT) participation is both crucial for medical advancement and an important treatment option, at times the only one, for oncological pts. However, only an estimate of ~3% of cancer pts worldwide enrolls into such trials. […]
The prevalence of Cannabis-related arrhythmias – Real world data evidence (RWDE) and patient’s reported outcomes (PRO) by using BELONG.life digital application (app).
Avishag Laish-Farkash, MD PhD, Luba Vasilenko, MD, Noy Moisa, BSc, Daniel Vorobiof, MD Cannabis consumption has been shown to cause arrhythmias with various ambiguous combinations, including ventricular tachycardia, and potentially sudden death. Suspected mechanisms are: effects of marijuana on cardiac ion channels and on the central nervous system. We aimed to investigate the RWDE and […]
